Aspreva Pharmaceuticals Corporation To Present At The Bank of America Health Care Conference In Las Vegas

VICTORIA, May 9 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation today announced that Richard Glickman, Chairman & CEO, will be presenting at the Banc of America Health Care Conference in Las Vegas.

The 5 minute presentation will be followed by a 25 minute Question and Answer period and will take place on Wednesday, May 17th at the Four Seasons Hotel, Las Vegas.

A live audio web cast of the presentation will be available for two weeks to all interested parties through a link posted on Aspreva's website at www.aspreva.com in the Investors section.

About Aspreva Pharmaceuticals

Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva's "Indication Partnering" strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population. Aspreva is listed on the NASDAQ National Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV".

For further information please contact: Sage Baker Executive Director, Corporate & Investor Affairs Aspreva Pharmaceuticals 250-744-2488 ext. 84270 sbaker@aspreva.com

CONTACT: Sage Baker, Executive Director, Corporate & Investor Affairs,Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com